US stock · data to 2026-10-20
Quest Diagnostics (DGX)
Quest Diagnostics: $234.92 on 2026-10-20. +15.1% a year since 1996, worst fall -49%. Year-by-year returns, risk profile and what followed its price patterns in the past.
Open the interactive chart and full historyKey numbers
| Last close | $234.92 |
| Return a year since 1996 | +15.1% |
| All-time high | $247.45 (2026-09-17) |
| Below its high | -5.1% |
| Worst fall | -49% (2003-02-14) |
| Yearly volatility | 29% |
| Beta vs its index | 0.61 |
| Risk / reward vs its market | Low risk · Medium reward |
Returns by year
| Year | Return |
|---|---|
| 2026 | +35.4% |
| 2025 | +15.0% |
| 2024 | +9.4% |
| 2023 | -11.9% |
| 2022 | -9.6% |
| 2021 | +45.2% |
| 2020 | +11.6% |
| 2019 | +28.2% |
| 2018 | -15.5% |
| 2017 | +7.2% |
| 2016 | +29.2% |
| 2015 | +6.1% |
What followed its price patterns in the past
How often DGX was higher 40 trading days after each pattern, next to an ordinary day. History for learning, not a forecast.
| Pattern | Past cases | Higher after 40 days | On an ordinary day | Median move |
|---|---|---|---|---|
| Up streak | 102 | 57% | 60% | +2.0% |
| Big up day | 94 | 61% | 60% | +3.1% |
| New 52-week high | 93 | 56% | 60% | +1.4% |
| RSI rises above 70 | 88 | 52% | 60% | +1.2% |
| Falls below 200-day avg | 75 | 60% | 60% | +2.8% |
| Down streak | 74 | 55% | 60% | +2.2% |
| Volume spike on a down day | 74 | 55% | 60% | +2.1% |
| Volume spike on an up day | 73 | 53% | 60% | +0.9% |
| Big down day | 71 | 56% | 60% | +0.7% |
| Crosses above 200-day avg | 71 | 66% | 60% | +2.9% |
| Falls 20% from all-time high | 56 | 55% | 60% | +1.7% |
| RSI drops below 30 | 51 | 69% | 60% | +5.0% |
ZOSH shows history and calculations for learning. It is not investment advice and does not tell anyone to buy or sell. Data: Yahoo Finance, AMFI, NSE and official sources; it can be late or wrong, so check before acting.